GLIMEPIRIDE 4mg. IP + METFORMIN 500mg. IP

An antihyperglycemic agent that treats high blood sugar levels caused by type 2 diabetes. An effective therapeutic choice for patients inadequately controlled on sulfonylurea or Metformin alone. (Anil Pareek, 2013) A potential agent that achieves good glycemic control with a better tolerability profile. (Anil Pareek, 2013) A beneficial option for patients with type 2 diabetes not controlled by diet and exercise and who want to achieve tight glucose control. (Campbell, 1998) A preferential option for most type 2 diabetes mellitus patients who have not achieved adequate control with monotherapy. (JM. Amate, 2015) An effective and well-tolerated antidiabetic drug that provides an important treatment option for managing type 2 diabetes. (Massi-Benedetti, 2003) Provides advantages over other currently available insulin secretagogues. (Davis, 2004) Reduces blood glucose levels and increases insulin levels in the blood. (Abdul Basit, 2012) Decreases blood sugar levels in a diabetic patient by increasing the production and secretion of insulin from the pancreas beta cells. (H D Langtry, 1998) Effectively decreases blood glucose levels and glycosylated hemoglobin fasting and postprandial state. (Fahir Becić, 2003)